HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Lämmle Selected Research

ADAMTS13 Protein

8/2003Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Case 2.
6/2003Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
8/2001Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus.
6/2001Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
6/2001von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome.
6/2001Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease.
4/2001Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Lämmle Research Topics

Disease

16Thrombotic Thrombocytopenic Purpura
01/2017 - 05/2000
7Thrombocytopenia (Thrombopenia)
01/2017 - 04/2001
7Hemorrhage
01/2014 - 03/2001
6Thrombotic Microangiopathies
01/2017 - 06/2001
5Hemolytic Anemia
01/2017 - 04/2001
5Thrombosis (Thrombus)
04/2016 - 07/2005
3Hemolytic-Uremic Syndrome
01/2017 - 07/2005
3Infections
01/2017 - 06/2001
3Neoplasms (Cancer)
01/2017 - 04/2001
3Venous Thrombosis (Deep-Vein Thrombosis)
10/2013 - 04/2001
2Sepsis (Septicemia)
11/2007 - 05/2001
2Fever (Fevers)
06/2003 - 06/2001
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2003 - 03/2001
2Ischemic Stroke
09/2001 - 07/2001
1COVID-19
01/2020
1Pre-Eclampsia (Preeclampsia)
01/2017
1Hemolysis
01/2017
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Hyperthyroidism
04/2016
1Hypothyroidism
04/2016
1Afibrinogenemia (Fibrinogen Deficiency)
11/2014
1Purpura
01/2014
1Factor X Deficiency
01/2014
1Immunoglobulin Light-chain Amyloidosis
01/2014
1Spontaneous Abortion (Miscarriage)
01/2014
1Rare Diseases (Rare Disease)
05/2013
1Venous Thromboembolism
03/2013
1Pancreatitis
10/2008
1Septic Shock (Toxic Shock Syndrome)
11/2007
1Transfusion-Related Acute Lung Injury
05/2006
1Transfusion Reaction
05/2006
1Diarrhea
08/2005
1Acute Disease
08/2005
1Myeloproliferative Disorders (Myeloproliferative Disorder)
08/2003
1Disease Susceptibility (Diathesis)
08/2003
1Renal Insufficiency (Renal Failure)
06/2003
1Pulmonary Embolism
04/2003
1Hypertension (High Blood Pressure)
08/2001
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2001
1Coronary Artery Disease (Coronary Atherosclerosis)
08/2001
1Diabetes Mellitus
08/2001
1Stroke (Strokes)
07/2001
1Purpura Fulminans
05/2001
1Disseminated Intravascular Coagulation
05/2001

Drug/Important Bio-Agent (IBA)

14thiamine triphosphorate (TTP)IBA
01/2017 - 04/2001
7ADAMTS13 ProteinIBA
08/2003 - 04/2001
5von Willebrand FactorIBA
01/2020 - 06/2001
5Fibrinogen (Factor I)FDA Link
11/2014 - 07/2001
4AnticoagulantsIBA
10/2013 - 03/2001
3Blood Coagulation Factors (Coagulation Factor)IBA
05/2015 - 07/2001
3fibrin fragment D (D-dimer)IBA
02/2005 - 04/2001
2Pharmaceutical PreparationsIBA
01/2017 - 01/2003
2Biomarkers (Surrogate Marker)IBA
04/2016 - 10/2013
2DNA (Deoxyribonucleic Acid)IBA
05/2015 - 10/2013
2Heparin (Liquaemin)FDA LinkGeneric
10/2009 - 07/2005
2coumarinIBA
01/2003 - 03/2001
2plasma protein Z (protein Z)IBA
09/2001 - 07/2001
1Factor VIII (Coagulation Factor VIII)IBA
01/2020
1EnzymesIBA
01/2017
1Thyroxine (Levothyroxine)FDA LinkGeneric
04/2016
1Thyroid HormonesIBA
04/2016
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
04/2016
1Peptides (Polypeptides)IBA
11/2014
1Proteins (Proteins, Gene)FDA Link
11/2014
1Amyloid (Amyloid Fibrils)IBA
01/2014
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2014
1ParaproteinsIBA
01/2014
1CreatinineIBA
11/2007
1ThrombomodulinIBA
11/2007
1Detergents (Detergent)IBA
05/2006
1Staphylococcal Protein A (Protein A)IBA
05/2006
1SolventsIBA
05/2006
1Ticlopidine (Ticlid)FDA LinkGeneric
08/2005
1Complement Factor H (Factor H)IBA
08/2005
1Immunoglobulins (Immunoglobulin)IBA
08/2003
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
08/2003
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
08/2003
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2003
1factor IX CambridgeIBA
01/2003
1CoumarinsIBA
01/2003
1Phenylbutazone (Butazolidin)FDA Link
01/2003
1fibrinmonomerIBA
08/2001
1CholesterolIBA
08/2001
1ThrombinFDA Link
07/2001
1Phospholipids (Phosphatides)FDA LinkGeneric
07/2001
1Vitamin KFDA Link
07/2001
1Factor VII (Proconvertin)IBA
07/2001
1CytokinesIBA
06/2001
1AntibodiesIBA
06/2001
1Protease Inhibitors (Protease Inhibitor)IBA
06/2001

Therapy/Procedure

4Therapeutics
10/2013 - 03/2001
1Transplantation
01/2017
1Liver Transplantation
11/2014
1Plasma Exchange
05/2006
1Hematopoietic Stem Cell Transplantation
08/2005
1Intravenous Infusions
08/2003
1Punctures
08/2003
1Stem Cell Transplantation
06/2003
1Drug Therapy (Chemotherapy)
06/2003
1Surgical Amputation (Amputations)
05/2001